Palvella Therapeutics (PVLA) Shares Issued (2013 - 2026)
Palvella Therapeutics (PVLA) reported Shares Issued of $956000.0 for Q1 2026, up 810.48% on a QoQ basis from $105000.0 in Q4 2025.
Palvella Therapeutics (PVLA) has 13 years of Shares Issued data on file, last reported at $956000.0 in Q1 2026.
- Quarterly Shares Issued changed N/A year-over-year to $956000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 97.14% YoY) and the FY2025 annual result came in at $763000.0, down 98.73% from the prior year.
- Shares Issued climbed to $956000.0 in Q1 2026 per PVLA's latest filing, from $105000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $60.0 million in Q4 2024 and bottomed at -$19.7 million in Q4 2023.
- The 5-year median for Shares Issued is $242000.0 (2025), against an average of $5.6 million.
- The widest annual swing landed in 2022, when Shares Issued jumped 32265.0%; it then plunged 21313.98% in 2023.
- Tracing PVLA's Shares Issued over 5 years: stood at $93000.0 in 2022, then sank by 21313.98% to -$19.7 million in 2023, then soared by 404.13% to $60.0 million in 2024, then tumbled by 99.83% to $105000.0 in 2025, then soared by 810.48% to $956000.0 in 2026.
- Per Business Quant, the three latest PVLA Shares Issued figures stand at $956000.0 (Q1 2026), $105000.0 (Q4 2025), and $242000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 956,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 956,000.00 |
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 416,000.00 |
| Jun 30, 2025 | 416,000.00 |
| Dec 31, 2024 | 60.00 Mn |
| Dec 31, 2024 | 60.00 Mn |
| Dec 31, 2023 | -19.73 Mn |
| Dec 31, 2023 | -19.73 Mn |
| Jun 30, 2023 | 19.73 Mn |
| Jun 30, 2023 | 19.73 Mn |
| Dec 31, 2022 | 93,000.00 |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | -6.38 Mn |
| Jun 30, 2022 | -6.38 Mn |
| Mar 31, 2022 | 6.47 Mn |
| Mar 31, 2022 | 6.47 Mn |
| Dec 31, 2021 | -18.08 Mn |
| Dec 31, 2021 | -18.08 Mn |
| Sep 30, 2021 | 18.62 Mn |
| Sep 30, 2021 | 18.62 Mn |
| Jun 30, 2021 | 272,000.00 |
| Jun 30, 2021 | 272,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Sep 30, 2020 | 9.70 Mn |
| Sep 30, 2020 | 9.70 Mn |
| Dec 31, 2019 | 31.00 Mn |
| Dec 31, 2019 | 31.00 Mn |
| Jun 30, 2019 | 97,000.00 |
| Jun 30, 2019 | 97,000.00 |
| Dec 31, 2018 | -669,000.00 |
| Dec 31, 2018 | -669,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Mar 31, 2018 | 47.21 Mn |
| Mar 31, 2018 | 47.21 Mn |
| Dec 31, 2017 | 2.94 Mn |
| Dec 31, 2017 | 2.94 Mn |
| Sep 30, 2017 | 200,000.00 |
| Sep 30, 2017 | 200,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Dec 31, 2016 | -21.00 |
| Dec 31, 2016 | -21.00 |
| Sep 30, 2016 | -59,651.00 |
| Sep 30, 2016 | -59,651.00 |
| Jun 30, 2016 | 16.50 Mn |
| Jun 30, 2016 | 16.50 Mn |
| Sep 30, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Mar 31, 2014 | 5,000.00 |
| Mar 31, 2014 | 5,000.00 |
| Dec 31, 2013 | 5,000.00 |
| Dec 31, 2013 | 5,000.00 |
| Jun 30, 2013 | 5,000.00 |
| Jun 30, 2013 | 5,000.00 |